Number of Shares
2.09 Mil
Current Holdings Value*
$45.80 Mil
% of Portfolio
8.86%
Total Estimate Gain
$-52.04 Mil
% of Total Estimate Gain
-27.19%

Octagon Capital Advisors LP's Apellis Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Octagon Capital Advisors LP held 2.09 Mil shares of Apellis Pharmaceuticals Inc(APLS), totaling $45.80 Mil. This investment constitutes 8.86% of their stock portfolio, and Octagon Capital Advisors LP now holds 1.67% of the outstanding Apellis Pharmaceuticals Inc(APLS) stock.

The initial trade took place in 2020Q4. And since then Octagon Capital Advisors LP has made 10 purchases of APLS, at an average price of $47.37, for a total of 4.04 Mil shares. In addition, there have been 4 sales at an average price of $51.67 for 1.95 Mil shares. Based on historical transaction data and APLS's current price of $18.51, Octagon Capital Advisors LP's estimated gain on his APLS holdings is $-52.04 Mil, reflecting a -27.19% gain to date.

Octagon Capital Advisors LP APLS ($18.51) Holding Chart

Octagon Capital Advisors LP APLS ($18.51) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1